TriSalus Life Sciences (TLSI) announced that it intends to offer to sell shares of its common stock in an underwritten public offering. All of the shares to be sold in the offering are to be sold by TriSalus. Lake Street Capital Markets is acting as the sole book-runner for the proposed offering.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TLSI:
- TriSalus Life Sciences Announces New Board Appointment
- TriSalus Life Sciences appoints Stansky to board of directors
- TriSalus Life Sciences sees FY26 revenue $60M-$62M, consensus $63.77M
- TriSalus Life Sciences reports preliminary Q4 revenue $13.2M, consensus $12.68M
- TriSalus Life Sciences named a 2026 Top Pick at Northland